Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Cancer Res. 2021 Mar 16;81(15):4145–4154. doi: 10.1158/0008-5472.CAN-20-3822

Table 2:

Quantitative Fluorescent Image Analysis

Parameter Trastuzumab Trastuzumab:1HE p-value

Positive Trastuzumab Area (SD) 26.52% (±8.11%) 43.32% (±11.42%) 0.0024
Mean Trastuzumab Fluorescence (SD) 13 MFI (±3) 15 MFI (±4) 0.25
Mean Trastuzumab Fluorescence for pixels above 10 (SD) 34 MFI (±5) 27 MFI (±3) 0.0034
Penetration Distance Limit (SD) 68.60 μm (±15.65 μm) 64.54 μm (±5.04 μm) 0.47
Grayscale Penetration Distance (SD) 39.38 μm (±5.89 μm) 51.52 μm (±5.15 μm) 0.0003
Percent of Grayscale to Limit (SD) 58.39% (±5.70%) 79.97% (±7.00%) <0.0001
Threshold Penetration Distance (SD) 41.30 μm (±6.70 μm) 58.24 μm (±5.40 μm) <0.0001
Percent of Threshold to Limit (SD) 61.15% (±6.26%) 90.34% (±6.02%) <0.0001